Goddess Secures Game-Changing Investment from IRIS Ventures to Fuel Global Expansion

by Iris Ventures

The brand pioneers an entirely new category: bioprotection™, a science-driven approach dedicated to safeguarding the health and longevity of hair. At its core lies the proprietary Goddess Molecule

Read more

Columbus Venture Partners participates in a $12.7M seed round of Accipiter Biosciences

by Columbus Venture Partners

The company has developed an advanced computational platform, combined with high-throughput experimentation, that uses proprietary methods to design multifunctional de novo proteins. These proteins, b...

Read more

EIB finances with €20 million Overture Life to invest in automatization of assisted reproductive processes

by Professional Newco

The European Investment Bank has signed a €20 million loan with Overture Life to invest in the automation of assisted reproductive processes and the use of AI to improve IVF (in-vitro fertilization)...

Read more

Esther Riambau, CEO and co-founder of Oniria Therapeutics: 'With the support of CDTI Innovación and the European MRR funds, we have been able to establish ourselves as a biotechnology company in precision oncology'

by CDTI Innovación

Oniria Therapeutics, with the support of CDTI Innovación and European funds from the Recovery and Resilience Facility (MRR), has developed ONR-001, an innovative preclinical drug aimed at delaying tu...

Read more

Ojer Pharma Laboratories, backed by Inveready, national winner of the 2025 Quality Innovation Award (QIA) in the SME Innovation category

by Inveready Asset Management

Ojer Pharma Laboratories has been recognized for its platform of sustained-release bioadhesive gels (GTP), a technology designed to optimize the efficacy and safety profile of dermatological treatment...

Read more

AstraZeneca Spain presents ACCIÓN, the accelerator for innovative healthcare projects, in collaboration with Wayra and Kunsen

by Wayra

AstraZeneca Spain, in collaboration with Wayra and Kunsen have presented ACCIÓN, the accelerator positioned as a benchmark for driving transformative solutions that will shape the future of the healt...

Read more

Xeltis, an Ysios portfolio company, secures nearly €50m from the EIB and existing shareholders to advance aXess

by Ysios Capital

It has secured €37.5m from the EIB, supported under the European Commission’s Invest EU programme, and €10m from existing investors, including EQT, investing from its LSP Health Economics Fund 2...

Read more

Moira Capital leads a €4 million capital increase in Bioflytech, with participation from CDTI and Xesgalicia

by Moira Capital Partners

Founded in 2012 and headquartered in Fuente Álamo, Bioflytech has established itself as the leading European company in insect protein production for animal feed, standing out for its technological i...

Read more

Sycai Medical develops, with support from the CDTI and MRR funds, an AI system capable of identifying premalignant lesions and cancer

by CDTI Innovación

In the field of diagnostic imaging, artificial intelligence is driving profound transformations that allow healthcare professionals to detect increasingly complex diseases at ever-earlier stages. Amon...

Read more

European Commission and EIB Group announce new initiative to mobilise €10 billion investment for Europe’s biotech sector

by Banco Europeo de Inversiones (BEI)

The European Commission and the European Investment Bank (EIB) Group have announced an initiative to mobilise €10 billion in investment in 2026-27 into the biotech and life sciences sector. The proj...

Read more

CDTI Innovación invests alongside Orza Gestión y Tenencia de Patrimonios AIE and Kutxa Fundazioa in Polimerbio

by CDTI Innovación

Polimerbio is a biotechnology company focused on the research, design, development, and manufacturing of biodegradable medical devices based on biomaterials, with extensive expertise in polymer chemis...

Read more

Seville-based biotech company PlusVitech completes a €3 million financing round to fight cancer

by CDTI Innovación

The transaction is structured in two tranches: a €2.5 million non-dilutive grant awarded by CDTI under the European Innovation Council (EIC) Seal of Excellence, and the closing of a €500,000 priva...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream